**Core Concept**
Tuberous sclerosis, also known as tuberous sclerosis complex (TSC), is a **genetic disorder** characterized by the growth of numerous non-cancerous tumors in many parts of the body. The underlying principle involves **mutations in the TSC1 or TSC2 genes**, leading to the formation of **hamartomas**.

**Why the Correct Answer is Right**
The correct answer involves tumors associated with tuberous sclerosis, including **angiomyolipomas**, **subependymal giant cell astrocytomas**, and **renal angiomyolipomas**. These tumors result from the **loss of function of the TSC1 or TSC2 genes**, which normally regulate **cell growth and division** by inhibiting the **mTOR pathway**.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it is not a comprehensive list of tumors associated with tuberous sclerosis.
**Option B:** Incorrect as it does not include all the characteristic tumors.
**Option C:** Incorrect because it is incomplete.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that tuberous sclerosis complex is associated with a range of tumors, and **early diagnosis** is crucial for managing the condition. The **mTOR pathway** plays a critical role in the pathogenesis of TSC.

**Correct Answer:** D. Angiomyolipoma, subependymal giant cell astrocytoma.